CD14 gene up-regulation in circulating leukocytes is consistent with emerging role of innate immunity in atherosclerosis.1 It is likely that plasma IL1 protein elevation reflects one of the downstream effects of activated innate immunity signaling. This evidence concerns the gene IL1B and atherosclerosis.